Volume 4
Journal of Infectious Diseases and Treatment
ISSN: 2472-1093
Page 52
Euro Infectious Diseases 2018 &
Histopathology 2018
September 27-29, 2018
&
JOINT EVENT
September 27-29, 2018 Rome, Italy
5
th
International Conference on
Histopathology & Cytopathology
10
th
Euro-Global Conference on
Infectious Diseases
Presence of
Mycobacterium
and other bacteria in lymphadenopathies with purulent aspirates
Assefa Wubshet, Bezabih Mesele, Abebe Gemeda
and
Tadesse Mulualem
Jimma University, Ethiopia
T
uberculosis(TB) is one of the biggest health challenges of the world. TB lymphadenopathy (TBL) is an important site of
involvement by extrapulmonary TB. Fine needle aspiration cytology (FNAC) is a cost effective and quick method for
diagnosis of such lesions. Although FNAC can offer a definite cytologic diagnosis of TBL in smears with caseaous aspirates,
those cases with purulent aspirates may be dismissed as suppurative lymphadenitis unless direct detection of
mycobacterium
performed. The study was aimed to assess presence of Mycobacterium and other bacteria in clinically TB suspected
lymphadenopathies with thin purulent aspirates after FNAC performed. The study was conducted from August to December
2017 in patients visiting Jimma University Medical Center (JUMC), South West Ethiopia. Fifty three TB suspected peripheral
lymphadenopathy (LAP) cases with purulent aspirates were enrolled and underwent cytomorphologic, LED and ZN staininig
evaluation; in which Mycobacterial infection detected in 49%, 43.4% and 9.4% cases respectively. Combining cytomorphology
with LED techniques increases the detection rate by 15% when compared with cytomorphology alone while AFB staining
increases this detection rate by 7.5%. Gram reaction observed in 17% of cases. We recommend the combined use of routine
FNAC with AFB staining and LED techniques to increases the detection of myocobacterial infection in purulent aspirates.
Performing Gram stain further help to reveal other bacterial causes of suppurative inflammation.
wubossassefa@yahoo.comJ Infec Dis Treat 2018, Volume 4
DOI: 10.21767/2472-1093-C1-003




